Christian Rommel - May 30, 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Director
Signature
/s/ AJ Silver, attorney-in-fact
Stock symbol
CRSP
Transactions as of
May 30, 2024
Transactions value $
$0
Form type
4
Date filed
5/31/2024, 04:15 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Stock Option (Right to Buy) Award $0 +26K $0.00 26K May 30, 2024 Common Shares 26K $54.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 30, 2024 with respect to 26,000 Common Shares, with 100% of the shares vesting in 36 equal monthly installments beginning on June 30, 2024.